The definition of heavy menstrual bleeding (HMB) has changed – it is no longer solely defined by millilitres of blood loss per cycle but now includes the impact on a women’s physical, social and emotional quality of life.1
>80%
of women say that HMB affects their relationship with their partner or their performance at work, and it affects attendance at school or work for 68% of sufferers.2
Download the interactive HELP treatment algorithm, including clinical considerations for all approved treatment options
Qlaira® Prescribing Information, Mirena® Prescribing Information,
The HELP group is an expert panel of physicians from 12 countries with a special interest in heavy menstrual bleeding (HMB), supported by Bayer.
A 30-minute, scientific e-learning course developed by the HELP expert panel of independent physicians*. Three case-based modules cover the diagnostic pathway and treatment algorithm for HMB to help you to counsel your patients effectively.
*The formation of the HELP expert panel and its ongoing work is supported by Bayer AG.
Reporting adverse events and quality complaints
If you want to report a side effect or quality complaint, please contact your health care professional (e.g. physician or pharmacist) or The Health Products Regulatory Authority, Reports can also be reported directly to Bayer through this link or by emailing directly on adr-reland@bayerhealthcare.com